Rituximab works for severe pemphigus but there are serious side effectsBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7615.324-b (Published 16 August 2007) Cite this as: BMJ 2007;335:324
Twenty one patients with severe pemphigus who didn't respond to treatment with corticosteroids or in whom treatment with corticosteroids was contraindicated were given four weekly infusions of rituximab—a monoclonal antibody directed against the CD20 antigen of B lymphocytes. The drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial